Mathieu Simon

Mathieu Simon holds a Doctor of Medicine (M.D.) degree in Internal Medicine from Paris VII Faculty of Medicine, attained between 1975 and 1983. Currently serving as Chairman of the Board at Idorsia Pharmaceuticals Ltd since May 2019 and at Aileens Pharma, Mathieu is also a member of the Board of Directors at Banook Group and has advisory responsibilities at Pureos Bioventures. Additional roles include Senior Strategic Advisor at Mediobanca, Director at the supervisory board of Affimed, and past positions as Director at Vaximm AG and Non-Executive Board Member at LYSOGENE. Mathieu's extensive experience includes leadership roles in investment banking, particularly in the healthcare sector.